Literature DB >> 19799696

Population-based screening for colorectal cancer: Australian research and implementation.

Graeme P Young1.   

Abstract

Australia is one of the first countries in the world to implement an organized whole-of-population screening program for colorectal cancer (CRC). Australians have made broad contributions to CRC in general ranging from primary prevention through genetics, secondary prevention and treatment, to palliation. This overview focuses on some of the contributions of direct relevance to population-based screening, stretching from technology development to population-based controlled studies and health services research. In terms of simple screening tests in a two-step screening strategy, the evidence is overwhelming that fecal immunochemical tests for hemoglobin (FITs) improve detection and are more acceptable. FIT-based screening is clearly acceptable to Australians and it has been demonstrated that a national organized screening program is feasible. In terms of benefit for Australians, with full roll out and high uptake by the population we could see the number of cases dying from CRC halved by this strategy. To this will be added the extra-screening benefits of improved diagnosis, improved treatment and improved public awareness, all benefits of other screening programs. CRC screening has progressed from a matter of irrelevance and distaste, to commonwealth government policy in the context of an organized program for all Australians.

Entities:  

Mesh:

Year:  2009        PMID: 19799696     DOI: 10.1111/j.1440-1746.2009.06069.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

Review 1.  Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.

Authors:  Andrea Iannone; Giuseppe Losurdo; Maria Pricci; Bruna Girardi; Antonio Massaro; Mariabeatrice Principi; Michele Barone; Enzo Ierardi; Alfredo Di Leo
Journal:  J Gastrointest Cancer       Date:  2016-06

2.  Screening practices of unaffected people at familial risk of colorectal cancer.

Authors:  Driss Ait Ouakrim; Alex Boussioutas; Trevor Lockett; Ingrid Winship; Graham G Giles; Louisa B Flander; Louise Keogh; John L Hopper; Mark A Jenkins
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-26

3.  Colorectal Neoplasia Differentially Expressed (CRNDE), a Novel Gene with Elevated Expression in Colorectal Adenomas and Adenocarcinomas.

Authors:  Lloyd D Graham; Susanne K Pedersen; Glenn S Brown; Thu Ho; Zena Kassir; Audrey T Moynihan; Emma K Vizgoft; Robert Dunne; Letitia Pimlott; Graeme P Young; Lawrence C Lapointe; Peter L Molloy
Journal:  Genes Cancer       Date:  2011-08

4.  Screening practices of Australian men and women categorized as "at or slightly above average risk" of colorectal cancer.

Authors:  Driss Ait Ouakrim; Trevor Lockett; Alex Boussioutas; Louise Keogh; Louisa B Flander; Ingrid Winship; Graham G Giles; John L Hopper; Mark A Jenkins
Journal:  Cancer Causes Control       Date:  2012-09-26       Impact factor: 2.506

Review 5.  Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.

Authors:  Esmée J Grobbee; Pieter Ha Wisse; Eline H Schreuders; Aafke van Roon; Leonie van Dam; Ann G Zauber; Iris Lansdorp-Vogelaar; Wichor Bramer; Sarah Berhane; Jonathan J Deeks; Ewout W Steyerberg; Monique E van Leerdam; Manon Cw Spaander; Ernst J Kuipers
Journal:  Cochrane Database Syst Rev       Date:  2022-06-06

Review 6.  Cost-effectiveness of colorectal cancer screening.

Authors:  Iris Lansdorp-Vogelaar; Amy B Knudsen; Hermann Brenner
Journal:  Epidemiol Rev       Date:  2011-06-01       Impact factor: 6.222

7.  A pilot study for using fecal immunochemical testing to increase colorectal cancer screening in Appalachia, 2008-2009.

Authors:  Brenda C Kluhsman; Eugene J Lengerich; Linda Fleisher; Electra D Paskett; Suzanne M Miller-Halegoua; Andrew Balshem; Marcyann M Bencivenga; Angela M Spleen; Paulette Schreiber; Mark B Dignan
Journal:  Prev Chronic Dis       Date:  2012       Impact factor: 2.830

8.  Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process.

Authors:  Yinghui Xu; Barcey T Levy; Jeanette M Daly; George R Bergus; Jeffrey C Dunkelberg
Journal:  BMC Health Serv Res       Date:  2015-04-23       Impact factor: 2.655

Review 9.  Colorectal cancer screening: tests, strategies, and perspectives.

Authors:  Fabrizio Stracci; Manuel Zorzi; Grazia Grazzini
Journal:  Front Public Health       Date:  2014-10-27

10.  Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study.

Authors:  Amy Duncan; Deborah Turnbull; Carlene Wilson; Joanne M Osborne; Stephen R Cole; Ingrid Flight; Graeme P Young
Journal:  BMC Public Health       Date:  2014-03-07       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.